Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-117260
Filing Date
2023-11-13
Accepted
2023-11-13 16:30:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm2330400-1_s3.htm S-3 344332
2 EXHIBIT 5.1 tm2330400d2_ex5-1.htm EX-5.1 11293
3 EXHIBIT 23.2 tm2330400d2_ex23-2.htm EX-23.2 2666
4 EXHIBIT 23.3 tm2330400d2_ex23-3.htm EX-23.3 2279
5 EX-FILING FEES tm2330400d2_exfilingfees.htm EX-FILING FEES 12943
6 GRAPHIC tm2330400d2_ex5-1img002.jpg GRAPHIC 2529
7 GRAPHIC lg_vynetherapeu-4c.jpg GRAPHIC 30936
  Complete submission text file 0001104659-23-117260.txt   421192
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275507 | Film No.: 231399321
SIC: 2834 Pharmaceutical Preparations